Molecular basis of the inflammatory response to adenovirus vectors
Top Cited Papers
- 20 May 2003
- journal article
- review article
- Published by Springer Nature in Gene Therapy
- Vol. 10 (11) , 935-940
- https://doi.org/10.1038/sj.gt.3302036
Abstract
Adenovirus vectors are extensively studied in experimental and clinical models as agents for gene therapy. Recent generations of helper-dependent adenovirus vectors have the majority of viral genes removed and result in vectors with a large carrying capacity, reduced host adaptive immune responses and improved gene transfer efficiency. Adenovirus vectors, however, activate innate immune responses shortly after administration in vivo. Unlike the adaptive response, the innate response to adenovirus vectors is transcription independent and is caused by the viral particle or capsid. This response results in inflammation of transduced tissues and substantial loss of vector genomes in the first 24 h. The adenovirus capsid activates a number of signaling pathways following cell entry including p38 mitogen-activated protein kinase and extracellular signal-regulated kinase (ERK) that ultimately lead to expression of proinflammatory genes. Various cytokines, chemokines and leukocyte adhesion molecules are induced by the adenovirus particle in a wide range of cell types providing a molecular basis for the inflammatory properties of these vectors. An understanding of the innate response to adenovirus vectors is essential to overcome the last remaining hurdle to improve the safety and effectiveness of these agents.Keywords
This publication has 55 references indexed in Scilit:
- MAP Kinases in the Immune ResponseAnnual Review of Immunology, 2002
- Acute Cytokine Response to Systemic Adenoviral Vectors in Mice Is Mediated by Dendritic Cells and MacrophagesMolecular Therapy, 2001
- Noncytolytic Control of Viral Infections by the Innate and Adaptive ImmuneResponseAnnual Review of Immunology, 2001
- Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeuticsNature Medicine, 2001
- Adenoviral Gene Therapy Leads to Rapid Induction of Multiple Chemokines and Acute Neutrophil-Dependent Hepatic Injury in VivoHuman Gene Therapy, 1999
- Innate Immune Mechanisms Dominate Elimination of Adenoviral Vectors FollowingIn VivoAdministrationHuman Gene Therapy, 1997
- A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signalProceedings of the National Academy of Sciences, 1996
- Adenoviruses as Gene-Delivery VehiclesNew England Journal of Medicine, 1996
- MHC class I-cestricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenovirusesImmunity, 1994
- Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.Proceedings of the National Academy of Sciences, 1994